Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e81afd7465ffba8139e557bd8c35b5eb |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-324 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-304 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-9789 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-105 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-105 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-9789 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 |
filingDate |
2021-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_330d773a28ecfdf891594774be623bb3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_022f92197c263ece141cd77c266a5bca http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_12288f734fb43513032c195ed461f72e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f6259e47302ad0c9d713c642c29486e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c92964a2d579b5ceeca73c5ed6e11548 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a7cbc011f974728fce9c62353f59f53e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_44b6e276ed58582ddab1457afec89746 |
publicationDate |
2021-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-20210098915-A |
titleOfInvention |
Composition for Anti-inflammation and Anti-allergy Using an Extract of Bistorta manshuriensis |
abstract |
The present invention has the activity of inhibiting NO production in a concentration-dependent manner in LPS (lipopolysaccharide)-stimulated mouse macrophage cell line (RAW 264.7 cells), and the mast cell line RBL-2H3 (rat) activated with IgE and antigen (DNP-BSA) basophilic leukemia), an anti-inflammatory composition and an anti-allergic composition using a pan-tailed extract having an activity of inhibiting degranulation when treated. |
priorityDate |
2019-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |